300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Travel
Platforms
InsurTech
Enterprise Software
Oil and Gas
Cryptocurrency
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Asbis, VC Fund

Asbis

VC Fund

Limassol, Cyprus

Asbis is a VC fund in Limassol focused on Biotechnology and Manufacturing. ASBIS Group is one of the leading distributors of Information Technology products in Europe, Middle East and Africa Emerging Markets: Central and Eastern Europe, the Baltic States, the Commonwealth of Independent States, the Middle East and Africa, combining a broad geographical reach with a wide range of products distributed on a"one-stop-shop" basis.

Total investments:
2
Last investment:
Lead investor:
100%

Last updated:

Industries Asbis invests in

BiotechnologyManufacturingHardwareSoftwarePharmaceutical

Stages Asbis invests in

SeedCorporate Round

Countries Asbis invests in

Cyprus

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

3 more contacts available

Investment Focus

Industry

  • Biotechnology 2 (100%)
  • Manufacturing 2 (100%)
  • Hardware 1 (50%)
  • Software 1 (50%)
  • Pharmaceutical 1 (50%)
See all 6 industries →

Stage

  • Seed 1 (50%)
  • Corporate Round 1 (50%)

Team

NameTitleInvestmentsLinksEmail
Serhei Kostevitch
Serhei Kostevitch Founder, CEO, President & Chairman
Founder, CEO, President & Chairman Total investments: 3
Find email
Vili Tajnic
Vili Tajnic VAD Team Lead
VAD Team Lead Total investments: 0
Find email

Investments

CompanyDescriptionRoundLinks
ProMed BioSciences ProMed BioSciences
Promed Bioscience is a provider of manufacture and supply of highly purified research and medical grade collagen from animal tissue.Collagen products are developed under carefully controlled conditions in order to meet strict customer specifications of quality and suitability for a wide range of research, clinical and cosmetic applications. $801.5K / Corporate Round / Nov 09, 2022
EMBIO Diagnostics EMBIO Diagnostics
Here’s a comprehensive description for **EMBIO Diagnostics**:---**EMBIO Diagnostics Ltd** is a cutting-edge deep-tech company specializing in **sensor technology** that ensures the safety and quality of air, water, and food. Based in **Nicosia, Cyprus**, EMBIO leverages advanced diagnostic tools and data-driven solutions to address criticalenvironmental challenges and enhance public health outcomes.### **Vision and Mission** - **Vision**: To revolutionize diagnostics with innovative technologies that foster a healthier and more sustainable future. - **Mission**: To deliver real-time, actionable insights through state-of-the-art sensor technology, empowering businesses, governments, and individuals to make informed decisions.---### **Core Products and Solutions**#### 1. **B.EL.D™ (Bio Electric Diagnostics)** - A portable chemical analyzer for **rapid diagnostics** in industries such as food safety, environmental monitoring, and healthcare. - **Key Features**: - Wireless and portable, with Bluetooth connectivity. - Real-time results within **3 minutes**. - No specialized training required for operation. - Cost-effective testing for allergens, contaminants, and more.#### 2. **airbeld™ System** - A comprehensive indoor air quality (IAQ) monitoring solution designed to: - Detect pollutants and harmful conditions in real-time. - Provide automated reports and notifications for actionable insights. - Integrate seamlessly with **Building Management Systems (BMS)**. - Includes advanced features like **EOS Insights**, which offers concise reports on environmental conditions.---### **Technological Advancements** EMBIO combines state-of-the-art **sensor technology**, **IoT integration**, and **AI-powered analytics** to provide real-time monitoring and predictive diagnostics. The company's solutions are designed to be user-friendly, efficient, and accessible, requiring minimal setup and expertise.---### **Global Impact** EMBIO Diagnostics is committed to addressing global sustainability and public health challenges by: - Reducing **environmental hazards**. - Enhancing **air, water, and food quality standards**. - Contributing to **research and policy-making** with accurate, real-time data.The company has established a global presence, delivering its solutions to markets across Europe, the Middle East, and beyond. By participating in initiatives like **Gitex Global 2024**, EMBIO showcases its leadership in **DeepTech** and its dedication to **sustainability**.---### **Collaborations and Innovations** EMBIO fosters partnerships with academic institutions, governments, and industry leaders to: - Advance research in diagnostics and environmental health. - Promote awareness of sustainability and safety standards. - Drive innovation through continuous R&D.---### **Leadership** Under the guidance of **Constantinos Loizou**, CEO of EMBIO Diagnostics, the company has become a pioneer in sensor technology. His vision has positioned EMBIO as a trusted name in global markets for tackling critical diagnostic challenges.---### **Why Choose EMBIO?** - **Cutting-Edge Technology**: Industry-leading tools for real-time monitoring and diagnostics. - **Commitment to Sustainability**: Solutions designed with environmental and social impact in mind. - **Global Expertise**: Proven track record of delivering impactful solutions across multiple industries.**Website**: **Headquarters**: Nicosia, Cyprus $1.1M / Seed / Dec 23, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Travel
Platforms
InsurTech
Enterprise Software
Oil and Gas
Cryptocurrency
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Enterprise
Community
Media (Entertainment)
Hardware
Biotech
Impact
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Asbis invest in?

Asbis invests primarily in Biotechnology, Manufacturing and Hardware startups, most often at Seed and Corporate Round stage. Most of the 2 investments tracked by Shizune back companies in Cyprus. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Asbis?

Public channels for Asbis include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Asbis?

The team at Asbis includes Serhei Kostevitch (Founder, CEO, President & Chairman) and Vili Tajnic (VAD Team Lead). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Asbis Asbis Find emails